Osimertinib, Third-generation EGFR-TKI, Targeted therapy for EGFR-mutated NSCLC, Inhibits EGFR Ex19Del and L858R mutations, Central nervous system activity,
Sale!
Lucius
Replica: Osimertinib 3rd Gen EGFR-TKI for EGFR-mutated NSCLC
Original price was: $657.00.$498.00Current price is: $498.00.
Osimertinib, Third-generation EGFR-TKI, Targeted therapy for EGFR-mutated NSCLC, Inhibits EGFR Ex19Del and L858R mutations, Central nervous system activity,
Reviews
There are no reviews yet.